-
1 Comment
China National Medicines Corporation Ltd is currently in a long term downtrend where the price is trading 22.4% below its 200 day moving average.
From a valuation standpoint, the stock is 93.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
China National Medicines Corporation Ltd's total revenue sank by 5.6% to $11B since the same quarter in the previous year.
Its net income has dropped by 29.0% to $378M since the same quarter in the previous year.
Finally, its free cash flow grew by 25.9% to $847M since the same quarter in the previous year.
Based on the above factors, China National Medicines Corporation Ltd gets an overall score of 2/5.
| Exchange | SHG |
|---|---|
| ISIN | CNE000001D56 |
| CurrencyCode | CNY |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| Beta | 0.41 |
|---|---|
| PE Ratio | 14.55 |
| Target Price | 40.92 |
| Market Cap | 29B |
| Dividend Yield | 1.9% |
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600511.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
